Evidence map›Paper›PMID 33306919›Full record

ArticleThe British journal of radiology2021

Diagnostic accuracy of non-contrast abdominopelvic computed tomography scans in follow-up of breast cancer patients.

Sang Yu Nam, Su Joa Ahn, Young Rock Jang, Yong Soon Chun, Heung Kyu Park, Seung Joon Choi, Hye Young Choi, Jeong Ho Kim

Abstract read
In one paragraph

Article in The British journal of radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sang Yu NamDepartment of Radiology, Gil Medical Center of Gachon University, Incheon, South Korea.
Su Joa AhnDepartment of Radiology, Gil Medical Center of Gachon University, Incheon, South Korea.
Young Rock JangDepartment of Internal Medicine, Gil Medical Center of Gachon University, Incheon, South Korea.
Yong Soon ChunDepartment of Surgery Breast Cancer Center, Gil Medical Center of Gachon University, Incheon, South Korea.
Heung Kyu ParkDepartment of Surgery Breast Cancer Center, Gil Medical Center of Gachon University, Incheon, South Korea.
Seung Joon ChoiDepartment of Radiology, Gil Medical Center of Gachon University, Incheon, South Korea.
Hye Young ChoiDepartment of Radiology, Gil Medical Center of Gachon University, Incheon, South Korea.
Jeong Ho KimDepartment of Radiology, Gil Medical Center of Gachon University, Incheon, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the effectiveness of follow-up with non-enhanced CT (NECT) in patients with breast cancer.

methodsThe present retrospective study included 1396 patients with breast cancer. Group A included patients with no metastasis to evaluate the diagnostic performance of NECT in detecting newly developed metastasis. Group B included patients with known hepatic metastasis to evaluate the accuracy of NECT for the assessment of hepatic metastasis.

resultsGroup A included 895 patients (mean age 52.8 years). Among them, 145 patients had 160 metastases. The per-patient sensitivities for diagnosing newly developed metastasis were 68.3 and 53.8% according to the two reviewers, while the per-lesion sensitivities were 89.4 and 85.0%. Sensitivities for bone metastasis were 98.9 and 95.9%, while sensitivities for hepatic metastasis were 73.7 and 68.4%. In group B, the accuracy of hepatic metastasis response evaluation according to the RECIST criteria was 70.8% for reviewer 1 and 63.8% for reviewer 2.

conclusionsNECT showed inadequate diagnostic performance in detecting newly developed metastasis and in evaluating the response of hepatic metastasis. However, NECT can be utilized as a follow-up modality in patients with decreased renal function or hypersensitivity to iodinated contrast media. ADVANCES IN KNOWLEDGE: The risk of side effects of contrast media should be considered as important when NECT can be utilized as a follow-up modality in decreased renal function patients.

Indexed as

Abdominal NeoplasmsAdultAgedAged, 80 and overBone NeoplasmsBreast NeoplasmsFemaleFollow-Up StudiesHumansLiver NeoplasmsMiddle AgedPelvic NeoplasmsReproducibility of ResultsRetrospective StudiesSensitivity and SpecificityTomography, X-Ray Computed

Identifiers

PMID33306919
PMCPMC7934306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.